Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles ; volume:12 ; number:1 ; day:3 ; month:10 ; year:2024 ; pages:1-13 ; date:12.2024
Cancer & metabolism ; 12, Heft 1 (3.10.2024), 1-13, 12.2024
- Urheber
-
Ali, Hassan A.
Karasinska, Joanna M.
Topham, James T.
Johal, Danisha
Kalloger, Steve
Metcalfe, Andrew
Warren, Cassia S.
Miyagi, Anthony
Tao, Lan V.
Kevorkova, Maya
Chafe, Shawn C.
McDonald, Paul C.
Dedhar, Shoukat
Parker, Seth J.
Renouf, Daniel J.
Schaeffer, David F.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40170-024-00357-z
- URN
-
urn:nbn:de:101:1-2412192215151.530852874481
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ali, Hassan A.
- Karasinska, Joanna M.
- Topham, James T.
- Johal, Danisha
- Kalloger, Steve
- Metcalfe, Andrew
- Warren, Cassia S.
- Miyagi, Anthony
- Tao, Lan V.
- Kevorkova, Maya
- Chafe, Shawn C.
- McDonald, Paul C.
- Dedhar, Shoukat
- Parker, Seth J.
- Renouf, Daniel J.
- Schaeffer, David F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction
Morphogenesis of pancreatic ductal adenocarcinoma-derived organoids
Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
Tumor organoids improve mutation detection of pancreatic ductal adenocarcinoma
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
Role of Pax6 in pancreatic endocrine cell subtype specification
Schizophrenia endothelial cells exhibit higher permeability and altered angiogenesis patterns in patient-derived organoids
Metabolic derangements in pancreatic cancer
Metabolic Derangements in Pancreatic Cancer
TNFα-mediated subtype switch and tumor progression in pancreatic cancer
Identification of vulnerabilities in an aggressive subtype of pancreatic cancer
Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction
Morphogenesis of pancreatic ductal adenocarcinoma-derived organoids
Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
Tumor organoids improve mutation detection of pancreatic ductal adenocarcinoma
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
Role of Pax6 in pancreatic endocrine cell subtype specification
Schizophrenia endothelial cells exhibit higher permeability and altered angiogenesis patterns in patient-derived organoids
Metabolic derangements in pancreatic cancer
Metabolic Derangements in Pancreatic Cancer
TNFα-mediated subtype switch and tumor progression in pancreatic cancer
Identification of vulnerabilities in an aggressive subtype of pancreatic cancer
Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction
Morphogenesis of pancreatic ductal adenocarcinoma-derived organoids
Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
Tumor organoids improve mutation detection of pancreatic ductal adenocarcinoma
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
Role of Pax6 in pancreatic endocrine cell subtype specification
Schizophrenia endothelial cells exhibit higher permeability and altered angiogenesis patterns in patient-derived organoids
Metabolic derangements in pancreatic cancer
Metabolic Derangements in Pancreatic Cancer
TNFα-mediated subtype switch and tumor progression in pancreatic cancer
Identification of vulnerabilities in an aggressive subtype of pancreatic cancer